Pentobarbital (US English) or pentobarbitone (UK English) is a short-acting barbiturate. Pentobarbital can occur as both a free acid and as salts of elements such as sodium and calcium. The free acid is only slightly soluble in water and ethanol.
One brand name for this drug is Nembutal, coined by John S. Lundy, who started using it in 1930, from the structural formula of the sodium salt—Na (sodium) + ethyl + methyl + butyl + al (common suffix for barbiturates). Nembutal is trademarked and manufactured by the Danish pharmaceutical company Lundbeck, and is the only injectable form of pentobarbital approved for sale in the United States.
In high doses, pentobarbital causes death by respiratory arrest. In the United States, the drug has been used for executions of convicted criminals. Lundbeck (one of a large number of manufacturers) doesn't permit its sale to prisons or corrections departments to carry out the death penalty.
Typical applications for pentobarbital are sedative, hypnotic for short term, preanesthetic and control of convulsions in emergencies.
It is additionally used as a veterinary anaesthetic agent.
Pentobarbital additionally has an application in reducing intracranial pressure in Reye's syndrome, traumatic brain injury and induction of coma in cerebral ischemia patients. Pentobarbital-induced coma has been advocated in patients with acute liver failure refractory to mannitol.
Pentobarbital can induce death when used in high doses. It is used for euthanasia for humans as well as nonhumans. It is additionally used by itself, or in combination with complementary agents such as phenytoin, in commercial animal euthanasia injectable solutions.
In the Netherlands, the standard protocol for physician-assisted suicide is intravenously induced thiopental anesthesia, followed by bromide of alcuronium- or pancuronium-induced respiratory arrest. A concentrated oral solution of 100 mL containing 9 grammes of pentobarbital sodium along with sugar syrup in a twenty percent ethanol solution is a standard solution used for self-administration by patient.
The oral dosage of pentobarbital indicated for physician-assisted death in the United States states of Oregon, Washington, Vermont, and California (as of January, 2016) is typically 10 g in liquid form. This is considerably higher than the dose for the management of status epilepticus.
Pentobarbital has been used or considered as a substitute for additional drugs traditionally used in the United States for execution when they're in short supply. Such use however is illegal under Danish law, and when this was discovered, after public outcry in Danish media, Lundbeck, the owner of the drug, stopped selling it to US States that practise death penalty. US distributors of the drug are forbidden by the owner to sell it to any customers, such as several state authorities, that practise or participate in executions of humans.
Texas began using pentobarbital for executing death row inmates by lethal injection on July 18, 2012. The use of pentobarbital has been considered by several states, including Ohio, Arizona, Idaho and Washington; those states made the decision to switch following shortages of pancuronium bromide, a muscle relaxant previously used as one component in a three-drug cocktail.
In October 2013, Missouri changed its protocols to allow for a compounded pentobarbital to be used in a lethal dose for executions. On November 20, 2013, Joseph Paul Franklin was executed by the state of Missouri. He was the first inmate executed in three years in the state and the first to die by a single dose of pentobarbital.
Pentobarbital undergoes first-pass metabolism in the liver and possibly the intestines.
Pentobarbital is synthesised by methods analogous to that of amobarbital, the only difference being that the alkylation of α-ethylmalonic ester is carried out with 2-bromopentane (not 1-bromo-3-methylbutane) to give pentobarbital.